Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rumi Mifuji

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Gastroenterology and Hepatology|January 21, 2004
Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria ratsMakoto Kuroda, Yoshinao Kobayashi, Yuji Tanaka, et al.
International Journal of Molecular Medicine|October 8, 2005
Transfecting the multidrug resistance protein 2 gene improves transcellular organic anion transportToshio Itani, Yoshinao Kobayashi, Makoto Kuroda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2004
Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn ratsKunihiro Higuchi, Yoshinao Kobayashi, Makoto Kuroda, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 3, 2015
Change in skeletal muscle mass after administering entecavir in patients with hepatitis BMotoh Iwasa, Ryosuke Sugimoto, Kyoko Yoshikawa, et al.
Obesity Research & Clinical Practice|February 5, 2015
Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatmentMotoh Iwasa, Tomoaki Ishihara, Rumi Mifuji-Moroka, et al.
Journal of Gastroenterology and Hepatology|March 23, 2007
Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver diseaseMika Yamamoto, Motoh Iwasa, Kazuko Iwata, et al.
Diabetes Research and Clinical Practice|October 22, 2011
Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis CMotoh Iwasa, Rumi Mifuji-Moroka, Nagisa Hara, et al.
Hepato-Gastroenterology|March 18, 2014
Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetesRumi Mifuji-Moroka, Motoh Iwasa, Hirohide Miyachi, et al.
Journal of Gastroenterology and Hepatology|May 19, 2006
Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis CRumi Mifuji, Yoshinao Kobayashi, Ning Ma, et al.
Journal of Nutritional Science and Vitaminology|February 16, 2016
Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular CarcinomaMotoh Iwasa, Ryosuke Sugimoto, Tomoaki Ishihara, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Gastroenterology and Hepatology|January 21, 2004
Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria ratsMakoto Kuroda, Yoshinao Kobayashi, Yuji Tanaka, et al.
International Journal of Molecular Medicine|October 8, 2005
Transfecting the multidrug resistance protein 2 gene improves transcellular organic anion transportToshio Itani, Yoshinao Kobayashi, Makoto Kuroda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2004
Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn ratsKunihiro Higuchi, Yoshinao Kobayashi, Makoto Kuroda, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 3, 2015
Change in skeletal muscle mass after administering entecavir in patients with hepatitis BMotoh Iwasa, Ryosuke Sugimoto, Kyoko Yoshikawa, et al.
Obesity Research & Clinical Practice|February 5, 2015
Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatmentMotoh Iwasa, Tomoaki Ishihara, Rumi Mifuji-Moroka, et al.
Journal of Gastroenterology and Hepatology|March 23, 2007
Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver diseaseMika Yamamoto, Motoh Iwasa, Kazuko Iwata, et al.
Diabetes Research and Clinical Practice|October 22, 2011
Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis CMotoh Iwasa, Rumi Mifuji-Moroka, Nagisa Hara, et al.
Hepato-Gastroenterology|March 18, 2014
Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetesRumi Mifuji-Moroka, Motoh Iwasa, Hirohide Miyachi, et al.
Journal of Gastroenterology and Hepatology|May 19, 2006
Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis CRumi Mifuji, Yoshinao Kobayashi, Ning Ma, et al.
Journal of Nutritional Science and Vitaminology|February 16, 2016
Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular CarcinomaMotoh Iwasa, Ryosuke Sugimoto, Tomoaki Ishihara, et al.
Pageof 3